Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Waters Corporation (WAT)
Waters Corporation stock price live, this page displays NYSE WAT stock exchange data. View the WAT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Waters Corporation real time stock price chart below.
What Is the Waters Corporation Stock Price Today?
The Waters Corporation stock price today is 349.53.
What Is the Stock Symbol for Waters Corporation?
The stock symbol for Waters Corporation is "WAT."
What Stock Exchange Does Waters Corporation Trade On?
Waters Corporation is listed and trades on the NYSE stock exchange.
Is Waters Corporation a Good Stock to Buy?
Determining whether Waters Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WAT quote. (ISIN: US9418481035)
What Is the Waters Corporation Stock Price Today?
The Waters Corporation stock price today is 349.53.
What Is the Stock Symbol for Waters Corporation?
The stock symbol for Waters Corporation is "WAT."
What Stock Exchange Does Waters Corporation Trade On?
Waters Corporation is listed and trades on the NYSE stock exchange.
Is Waters Corporation a Good Stock to Buy?
Determining whether Waters Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WAT quote. (ISIN: US9418481035)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
341.19
353.53
52 wk Range
275.05
414.15
WAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
341.19353.53
52 wk Range
275.05414.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WAT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
388.23
Upside
+11.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Waters Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
13 Buy
9 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 388.23
(+11.07% Upside)
Waters Corporation SWOT Analysis
Biologics Boost | Waters Corporation strategically positions itself in the rapidly expanding biologics market, with acquisitions and product developments strengthening its offerings in this high-growth sector. |
Financial Health | Explore Waters' robust financial metrics, including a 59.3% gross profit margin and nearly $3 billion in annual revenue, underpinning its strategic initiatives and market expansion. |
Market Dynamics | Delve into the projected 10.3% CAGR of the biologics market through 2028, and how Waters' specialized expertise in QA/QC for biopharmaceuticals positions it for potential outperformance. |
Analyst Outlook | Analyst price targets range from $360 to $460, reflecting varied perspectives on Waters' growth potential amid its focus on high-growth areas like GLP-1 treatments and biologics. |
Waters Corporation Earnings Call Summary for Q1/2026
- Waters posted Q1 2026 EPS of $2.70, beating estimates of $2.31; revenue hit $1.27B vs. $1.20B forecast, driving 10.64% pre-market stock surge to $334.
- Strong performance driven by successful integration of BD's Biosciences and Diagnostic Solutions acquisition; adjusted operating margin reached 23.6%.
- CEO Udit Batra highlighted exceptional operational execution and strong positioning for continued growth trajectory and shareholder value delivery.
- Company faces headwinds including GAAP diluted loss of $(0.87) per share from acquisition charges and Biosciences Division challenges in China market.
- Management issued optimistic guidance expecting continued revenue and EPS growth, supported by upcoming product launches and strategic expansion initiatives.
Last Updated: 2026-05-05, 10:04 a/m
Read Full TranscriptEarnings
Latest Release
May 05, 2026
EPS / Forecast
2.70 / 2.31
Revenue / Forecast
1.27B / 1.2B
Compare WAT to Peers and Sector
Metrics to compare | WAT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWATPeersSector | |
|---|---|---|---|---|
P/E Ratio | 76.3x | 21.3x | −0.5x | |
PEG Ratio | −2.05 | 0.36 | 0.00 | |
Price/Book | 2.2x | 3.3x | 2.6x | |
Price / LTM Sales | 9.1x | 2.7x | 3.2x | |
Upside (Analyst Target) | 9.2% | 34.2% | 48.3% | |
Fair Value Upside | Unlock | 11.0% | 5.6% | Unlock |
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Waters (WAT) Stock Price Today?
The Waters stock price today is 349.53 USD.
What Stock Exchange Does Waters Trade On?
Waters is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Waters?
The stock symbol for Waters is "WAT."
What Is the Waters Market Cap?
As of today, Waters market cap is 34.31B USD.
What Is Waters's Earnings Per Share (TTM)?
The Waters EPS (TTM) is 10.76.
When Is the Next Waters Earnings Date?
Waters will release its next earnings report on Aug 04, 2026.
From a Technical Analysis Perspective, Is WAT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Waters Stock Split?
Waters has split 2 times.
How Many Employees Does Waters Have?
Waters has 16000 employees.
What is the current trading status of Waters (WAT)?
As of May 07, 2026, Waters (WAT) is trading at a price of 349.53 USD, with a previous close of 342.75 USD. The stock has fluctuated within a day range of 341.19 USD to 353.53 USD, while its 52-week range spans from 275.05 USD to 414.15 USD.
What Is Waters (WAT) Price Target According to Analysts?
The average 12-month price target for Waters is 388.23 USD, with a high estimate of 480 USD and a low estimate of 330 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +11.07% Upside potential.
What Is the WAT Premarket Price?
WAT's last pre-market stock price is 342.53 USD. The pre-market share volume is 610.00, and the stock has decreased by -0.22, or -0.06%.
What Is the WAT After Hours Price?
WAT's last after hours stock price is 349.99 USD, the stock has decreased by 0.46, or 0.13%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.